CoChat

A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project

Open access
El-Achkar, Tarek M., Eadon, Michael T., Menon, Rajasree, Lake, Blue B., Sigdel, Tara K., Alexandrov, Theodore, Parikh, Samir, Zhang, Guanshi, Dobi, Dejan, Dunn, Kenneth W., Otto, Edgar A., Anderton, Christopher R., Carson, Jonas M., Luo, Jinghui, Park, Chris, Hamidi, Habib, Zhou, Jian, Hoover, Paul, Schroeder, Andrew, Joanes, Marianinha, Azeloglu, Evren U., Sealfon, Rachel, Winfree, Seth, Steck, Becky, He, Yongqun, D’Agati, Vivette, Iyengar, Ravi, Troyanskaya, Olga G., Barisoni, Laura, Gaut, Joseph, Zhang, Kun, Laszik, Zoltan, Rovin, Brad H., Dagher, Pierre C., Sharma, Kumar, Sarwal, Minnie M., Hodgin, Jeffrey B., Alpers, Charles E., Kretzler, Matthias, Jain, Sanjay · 2021 · Physiological Genomics
Cited by 74

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Comprehensive and spatially mapped molecular atlases of organs at a cellular level are a critical resource to gain insights into pathogenic mechanisms and personalized therapies for diseases. The Kidney Precision Medicine Project (KPMP) is an endeavor to generate three-dimensional (3-D) molecular atlases of healthy and diseased kidney biopsies by using multiple state-of-the-art omics and imaging technologies across several institutions. Obtaining rigorous and reproducible results from disparate methods and at different sites to interrogate biomolecules at a single-cell level or in 3-D space is a significant challenge that can be a futile exercise if not well controlled. We describe a “follow the tissue” pipeline for generating a reliable and authentic single-cell/region 3-D molecular atlas of human adult kidney. Our approach emphasizes quality assurance, quality control, validation, and harmonization across different omics and imaging technologies from sample procurement, processing, storage, shipping to data generation, analysis, and sharing. We established benchmarks for quality control, rigor, reproducibility, and feasibility across multiple technologies through a pilot experiment using common source tissue that was processed and analyzed at different institutions and different technologies. A peer review system was established to critically review quality control measures and the reproducibility of data generated by each technology before their being approved to interrogate clinical biopsy specimens. The process established economizes the use of valuable biopsy tissue for multiomics and imaging analysis with stringent quality control to ensure rigor and reproducibility of results and serves as a model for precision medicine projects across laboratories, institutions and consortia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/physiolgenomics.00104.2020

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 74

Metadata

Authors
El-Achkar, T. M., Eadon, M. T., Menon, R., Lake, B. B., Sigdel, T. K., Alexandrov, T., Parikh, S., Zhang, G., Dobi, D., Dunn, K. W., Otto, E. A., Anderton, C. R., Carson, J. M., Luo, J., Park, C., Hamidi, H., Zhou, J., Hoover, P., Schroeder, A., Joanes, M., Azeloglu, E. U., Sealfon, R., Winfree, S., Steck, B., He, Y., D’Agati, V., Iyengar, R., Troyanskaya, O. G., Barisoni, L., Gaut, J., Zhang, K., Laszik, Z., Rovin, B. H., Dagher, P. C., Sharma, K., Sarwal, M. M., Hodgin, J. B., Alpers, C. E., Kretzler, M., & Jain, S.
Venue
Physiological Genomics
Published
2021-01-01
Volume
53
Issue
1
Pages
1-11
ISSN
  • 1094-8341 (ISSN-L)
  • 1531-2267
OpenAlex
W3100860590
Cited by
74
References
11
FWCI
3.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.